Winning Health(SZ:300253) Sou Hu Cai Jing·2025-07-14 09:30Core Viewpoint - The company, Weining Health, is experiencing a significant decline in its financial performance, with a high price-to-earnings (PE) ratio compared to industry averages, indicating potential overvaluation in the market [1][2]. Company Summary - Weining Health's stock closed at 10.25 yuan, down 1.54%, with a rolling PE ratio of 296.23 times, and a total market capitalization of 22.68 billion yuan [1]. - The company operates in the software development industry, which has an average PE ratio of 119.15 times and a median of 86.84 times, placing Weining Health at the 176th position in the industry ranking [1][2]. - The main business of Weining Health includes research and development, sales, and technical services, focusing on integrated healthcare information solutions [1]. Financial Performance - In the first quarter of 2025, Weining Health reported a revenue of 345 million yuan, a year-on-year decrease of 30.24%, and a net profit of 5.29 million yuan, down 68.18% compared to the previous year, with a gross profit margin of 34.46% [1]. - On July 14, the company experienced a net outflow of 38.70 million yuan in principal funds, although there was an overall inflow of 103.45 million yuan over the past five days [1].